Standout Papers

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy 2006 2026 2012 2019 2.2k
  1. Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy (2006)
    Steven E. Kahn, Steven M. Haffner et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 14 from Science/Nature 127 standout
Sub-graph 1 of 17

Citing Papers

Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2022 Standout
Pharmacological treatment of hyperglycemia in type 2 diabetes
2021 Standout
62 intermediate papers

Works of Mark Heise being referenced

Rosiglitazone-Associated Fractures in Type 2 Diabetes
2008
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy
2006 Standout
and 6 more

Author Peers

Author Last Decade Papers Cites
Mark Heise 1928 2513 923 25 3.5k
Barbara G. Kravitz 1902 2378 894 23 3.5k
Mark O’Neill 1289 1938 793 12 2.5k
Keith Usiskin 1559 3222 1798 40 4.2k
Alan C. Moses 2230 3628 1179 82 5.5k
Deborah A. Robins 941 1633 591 26 2.4k
Jennifer Sugg 1597 2742 1453 64 4.4k
Michael A. Bush 816 2247 1059 31 4.4k
David Polidori 1285 3128 2001 64 3.9k
Giuseppe Daniele 1049 1608 975 61 2.6k
Glenn J. Gormley 531 1327 540 42 4.0k

All Works

Loading papers...

Rankless by CCL
2026